Feedback / Questions
Cimerli (ranibizumab-eqrn) - Amneal, Formycon, Coherus Oncology, Teva, Bio Usawa, Bioeq AG
https://www.formycon.com/en/blog/press-release/bio-usawa-becomes-partner-for-the-commercialization-of-fyb201-bioucenta-ranibizumab-across-sub-saharan-africa/
Jul 1, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next